NEW HAVEN, Conn., March 2, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it plans to release fourth quarter and full year 2011 financial results on Thursday, March 8, 2012, before the market opens.
Achillion will also host a conference call and live webcast to discuss these financial results and to provide an update on the Company's hepatitis C (HCV) development programs that morning at 8:30 a.m. ET.
To participate in the conference call, please dial (877) 266-0482 in the U.S. or (631) 291-4567 for international callers. A live audio webcast of the call will be accessible at www.achillion.com, under the News Center section of the website. Please connect to Achillion's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
A replay of the webcast will be available on www.achillion.com. Alternatively, a replay of the conference call can be accessed beginning at 12:30 p.m. ET on March 8, 2012, through 11:59 p.m. ET on March 15, 2012 by dialing (800) 585-8367 or (404) 537-3406. The replay passcode is 58851443.
About Achillion Pharmaceuticals
Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including hepatitis C and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.